One of the major targets of TET1 is RASSF5, a tumor suppressor—as TET1 overexpression upregulates RASSF5 expression by inhibiting the hypermethylation of the RASSF5 promoter (Figure 6d) [126,127]. Here, RASSF5 is linked to neoplasm.